FR3133311A1 - COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ALKYLPOLYGLUCOSIDE, AT LEAST ONE UV FILTER AND ISOPROPYL MYRISTATE - Google Patents

Abstract

Title: COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ALKYLPOLYGLUCOSIDE, AT LEAST ONE UV FILTER AND ISOPROPYL MYRISTATE The present invention relates to a cosmetic or dermatological composition in the form of an emulsion comprising in a physiologically acceptable at least one aqueous phase, at least one oily phase, at least one copolymer comprising at least one monomer of 2-acrylamido-2-methylpropane sulfonic acid (AMPS®) and at least one monomer with a hydrophobic group, at least one system emulsifier comprising at least one alkylpolyglucoside, at least one UV filter, and isopropyl myristate.

Description

COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ALKYLPOLYGLUCOSIDE, AT LEAST ONE UV FILTER AND ISOPROPYL MYRISTATE

The present invention relates to a cosmetic or dermatological composition in the form of an emulsion comprising in a physiologically acceptable support at least one aqueous phase, at least one oily phase, at least one copolymer comprising at least one 2-acrylamido-acid monomer. 2-methylpropane sulfonic acid (AMPS®) and at least one monomer with a hydrophobic group, at least one emulsifying system comprising at least one alkylpolyglucoside, at least one UV filter, and isopropyl myristate.

In the cosmetic field, more and more consumers are looking for cosmetic products not only intended for the care of keratin materials, but also possessing photoprotective activity for keratin materials, while remaining very demanding in terms of sensory qualities and performance. of these.

It is in fact well known that light radiation with wavelengths between 280 nm and 400 nm allows the browning of the human epidermis and that rays with wavelengths between 280 and 320 nm, known under the name d 'UV-B, causes erythema and skin burns; this UV-B radiation must therefore be filtered.

We also know that UV-A rays, with wavelengths between 320 and 400 nm, which cause browning of the skin, are likely to induce an alteration of the latter, particularly in the case of skin sensitive or skin continuously exposed to solar radiation. UV-A rays in particular cause a loss of skin elasticity and the appearance of wrinkles leading to premature aging. They promote the triggering of the erythematous reaction or amplify this reaction in certain subjects and can even be the cause of phototoxic or photoallergic reactions. It is therefore desirable to also filter UV-A radiation.

UVA and UVB rays must therefore be filtered and there are currently cosmetic compositions that protect the human epidermis containing UVA filters.
and UVB.

Compositions for the care of keratin materials comprising at least one UVA and/or UVB filter are generally in the form of an emulsion, of the oil-in-water type (i.e. a cosmetically and/or dermatologically acceptable support consisting of of a continuous aqueous dispersing phase and a discontinuous fatty dispersed phase) or water-in-oil (aqueous phase dispersed in a continuous fatty phase), which contains, at various concentrations, one or more conventional lipid-soluble organic filters and/ or conventional water-soluble organic filters capable of selectively absorbing harmful UV radiation, these filters (and their quantities) being selected according to the desired sun protection factor, the sun protection factor (SPF) being expressed mathematically by the ratio of the dose of UV radiation necessary to reach the erythematogenous threshold with the UV filter with the dose of UV radiation necessary to reach the erythematogenous threshold without the UV filter. In such emulsions, the hydrophilic filters are present in the aqueous phase and the lipophilic filters are present in the fatty phase. There are also multiple emulsions obtained after dispersion of an inverse emulsion in an aqueous phase.

The use of certain organic filters in these emulsions for the care of keratin materials tends to deteriorate their sensory qualities, when taking the composition from the jar (when the formulas are packaged in this way), but also during their application on the skin. skin. Thus, the presence of organic UV filters leads in particular to less slippery spreading and a greater transformation of the texture into oil. In addition, the skin finish is also altered by the presence of such filters, and results in formulas that are waxier (presenting a rougher skin finish) and stickier (presenting a stickier skin finish).

The aim of the present invention is therefore to have a specific combination of raw materials making it possible to formulate compositions for the care of keratin materials in the form of emulsions with the use of UV filters, in particular organic, without the disadvantages stated above.

This need is all the stronger as the daily photoprotection market is booming. More and more hybrid products providing skin care and protection at SPF 15-20 are being launched, but the challenge remains to provide pleasant sensoriality for daily application. The world of skin care remains very different from the field of photoprotection in terms of consumer experience, particularly with products sold in jars, which increases the complexity of formulatory development.

We are therefore looking to have a product with SPF while keeping the sensory codes of skin care: Appearance, texture, consistency, sensory.

In other words, the aim of the invention is to develop a product with an interesting sensory effect, in particular with a soft and non-sticky skin finish and good spreading properties (slippery and limited transformation into oil), allowing daily photoprotection and which can be marketed in packaging conventionally used in the field of skin care, in particular a pot formulation.

The present invention aims precisely to meet these needs.

The subject of the present invention is a cosmetic or dermatological composition in the form of an emulsion comprising in a physiologically acceptable support:

a) at least one aqueous phase

b) at least one oily phase

c) at least one copolymer comprising at least one monomer of 2-acrylamido-2-methylpropane sulfonic acid (AMPS®) and at least one monomer with a hydrophobic group,

d) at least one emulsifying system comprising at least one alkylpolyglucoside.

e) at least one UV filter, and

f) isopropyl myristate.

The present invention also relates to a process for the cosmetic treatment of keratin materials in which a composition as defined above is applied to said keratin materials.

The invention also relates to the use of a composition as defined above for the cosmetic treatment of keratin materials.

Against all expectations, the inventors have found that a composition in the form of an emulsion comprising at least one AMPS® copolymer in association with at least one emulsifying system comprising at least one alkylpolyglucoside, at least one UV filter and myristate isopropyl with improved spreading qualities, softness to the touch and/or non-stickiness.

The invention is not limited to the examples illustrated. The characteristics of the different examples can in particular be combined in variants not illustrated.

The expression “ comprising a ” must be understood to mean “comprising at least one”, unless the contrary is specified.

The expressions “ at least one ” and “at least” used in this description are respectively equivalent to the expressions “one or more” and “greater or equal”.

By “ keratin materials ” according to the invention is meant the skin of the body, face and/or eye contour, lips, nails, mucous membranes, eyelashes, eyebrows, hair, scalp and/or hair, or any other skin area of the body. More particularly, the keratin materials according to the invention are the scalp, the hair, and/or the skin.

Preferably, the keratin materials according to the invention are skin.

By “ the skin ”, we mean the entire skin of the body, and preferably, the skin of the face, neckline, neck, arms and forearms, or even more preferably, the skin of the face, especially the forehead, nose, cheeks, chin, eye area.

By “ copolymer ” we mean both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers such as terpolymers obtained from three kinds of monomers.

For the purposes of the present invention, we mean:

- “ SPF ” (Sun Protection Factor in English): the sun protection factor, which measures the level of protection against UVB. The SPF value corresponds to the ratio between the minimum time it takes to get a sunburn with a sunscreen composition and that without a product. More precisely, the term “ SPF ” is defined in the article A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum , J. Soc. Cosmetic. Chem., 40, 127-133 (May/June 1989).

The assessment of SPF (Sun Protection Factor) can be carried out in vitro using the Labsphere® spectrophotometer. The plate is the material on which the anti-solar composition is applied. For this protocol, polymethylmethacrylate (PMMA) plates proved ideal.

The evaluation of the Sun Protection Factor (SPF) of the compositions can also be carried out in-vivo according to the ISO/EN 24444 protocol “Cosmetics-Sun protection test methods-In-vivo determination of the sun protection factor (SPF) ( 2010).

- “ PPD ” (Persistent Pigment Darkening in English): the index characterizing UVA protection. In particular, the “ PPD ” measures the color of the skin observed 2 to 4 hours after exposure to UVA. This method has been adopted since 1996 by the Japanese Cosmetic Industry Association (JCIA) as the official testing procedure for UVA labeling of products and is frequently used by testing laboratories in Europe and the United States; (Japan Cosmetic Industry Association Technical Bulletin. Measurement Standards for UVA protection efficacy. Issued November 21, 1995 and effective of January 1, 1996).

Preferably, the composition according to the invention is a cosmetic composition, more preferably a cosmetic composition for treating keratin materials such as the skin.

AMPS® copolymer

The composition according to the invention comprises at least one copolymer comprising at least one monomer of 2-acrylamido-2-methylpropane sulfonic acid (AMPS®) and at least one monomer with a hydrophobic group.

For the purposes of the present invention, the term hydrophobic group means a fatty hydrocarbon chain comprising from 6 to 50 carbon atoms, branched or not, saturated or unsaturated.

The AMPS® copolymer(s) may be crosslinked. When they are, the crosslinking agents can be chosen from the polyolefinically unsaturated compounds commonly used for the crosslinking of polymers obtained by radical polymerization.

By crosslinked copolymer is meant a non-linear copolymer in the state of a three-dimensional network insoluble in water but swellable in water and leading to the production of a chemical gel.

The crosslinking agent is more particularly chosen from ethylene glycol dimethacrylate, tetraallyloxyethane, ethylene glycol diacrylate, diallyl urea, triallyl amine, trimethylol propane triacrylate or methylene-bis(acrylamide) or a mixture of these compounds. Preferably, the crosslinking agent is trimethylol propane triacrylate.

Preferably, the AMPS® copolymer(s) are crosslinked by a crosslinking agent, preferably trimethylol propane triacrylate.

The 2-acrylamido-2-methylpropane sulfonic acid monomer(s) of the copolymer contained in the composition according to the invention are in free form or are neutralized partially or totally by a mineral base (soda, potassium hydroxide, ammonia) or an organic base such as mono-, di-, or tri-ethanolamine, an aminomethylpropanediol, N-methyl-glucamine, basic amino acids such as arginine and lysine as well as the mixture of these compounds.

According to the invention, the 2-acrylamido-2-methylpropane sulfonic acid (AMPS®) monomers preferably correspond to the following general formula (I):

(I)

In which X ⁺ designates a cationic counterion, in particular an alkali or alkaline earth metal, or an ammonium, preferably ammonium, or a mixture of cations; R ₁ designates a hydrogen atom or a linear or branched C ₁ -C ₆ alkyl radical such as methyl, preferably R1 designates a hydrogen atom.

Preferably, the 2-acrylamido-2-methylpropane sulfonic acid monomer(s) according to the invention are partially or completely salified in the form of ammonium salt.

More preferably, the 2-acrylamido-2-methylpropane sulfonic acid monomer(s) according to the invention are completely salified, preferably in the form of ammonium salt.

The AMPS® copolymer(s) comprise at least one monomer with a hydrophobic group which is preferably an ethylenically unsaturated monomer comprising at least one hydrocarbon fatty chain portion comprising from 6 to 50 carbon atoms, preferably from 6 to 22 and more particularly from 12 to 18 carbon atoms.

This hydrophobic ethylenically unsaturated monomer is preferably chosen from acrylates or acrylamides of formula (II):

(II)

in which R ₁ denotes a hydrogen atom or a linear or branched C ₁ -C ₆ alkyl radical, preferably methyl; Y denotes O or NH; R ₂ designates a hydrophobic hydrocarbon radical comprising from 6 to 50 carbon atoms and more preferably from 6 to 22 carbon atoms and even more preferably from 12 to 18 carbon atoms; x denotes a number ranging from 0 to 100.

According to a preferred embodiment of the invention, in formula (II), Y designates an oxygen atom.

According to a preferred embodiment of the invention, in formula (II), the group R ₁ represents a methyl.

According to a particular embodiment of the invention, x represents an integer between 3 and 25.

According to a preferred embodiment of the invention, in formula (II), the group R ₂ represents an alkyl radical comprising from 12 to 18 carbon atoms.

According to an even more preferred embodiment of the invention, in formula (II), Y designates an oxygen atom, the group R ₁ represents a methyl, the group R ₂ represents an alkyl radical comprising from 12 to 18 atoms of carbon, and x represents an integer between 3 and 25.

Preferably, the monomer with a hydrophobic group of formula (II) is ethoxylated stearyl methacrylate (25OE) corresponding to the compound of formula (II) in which the group R ₁ represents a methyl, the group Y denotes O, the group R ₂ represents an alkyl radical containing 18 carbon atoms and x is equal to 25.

According to a particular embodiment of the invention, the monomer with a hydrophobic group of formula (II) is tetraethoxylated lauryl methacrylate (4OE), corresponding to the compound of formula (II) in which the group R ₁ represents a methyl, the group Y denotes O, group R ₂ represents an alkyl radical containing 12 carbon atoms and x is equal to 4.

In this embodiment, the monomer with a hydrophobic group is preferably tetraethoxylated lauryl methacrylate.

According to another particular embodiment of the invention, the AMPS® copolymer may comprise at least one monomer of formula (II) in which x is equal to 0, with preferably Y designating an oxygen atom, the group R1 representing a methyl, the group R2 represents an alkyl radical containing from 12 to 18 carbon atoms.

In this embodiment, the monomer with a hydrophobic group is preferably lauryl methacrylate.

According to another particular embodiment, the AMPS® copolymer comprises at least one monomer of formula (II) in which x is equal to 0, with preferably Y designating an oxygen atom, the group R ₁ representing a methyl , the group R ₂ represents an alkyl radical comprising from 12 to 18 carbon atoms and at least one monomer of formula (II) in which Y designates an oxygen atom, the group R ₁ represents a methyl, the group R ₂ represents an alkyl radical comprising 12 to 18 carbon atoms, and x represents an integer between 3 and 25, preferably x is equal to 4.

In this embodiment, the AMPS® copolymer preferably comprises, as monomers with a hydrophobic group, lauryl methacrylate and tetraethoxylated lauryl methacrylate.

Preferably, the monomer with a hydrophobic group is ethoxylated stearyl methacrylate (25OE).

According to a particular embodiment of the invention, the AMPS® copolymer may further comprise at least one ethylenically unsaturated monomer not comprising a hydrophobic group preferably corresponding to the following general formula (III):

(III)

in which R ₁ designates a hydrogen atom or a linear or branched C ₁ -C ₄ alkyl radical, preferably R ₁ designates a hydrogen atom, R ₂ designates a linear or branched C ₁ -C alkyl radical ₄ and R ₃ designates a linear or branched C ₁ -C ₄ alkyl radical, preferably R ₂ and R ₃ designate a methyl.

The ethylenically unsaturated monomer not comprising a hydrophobic group is chosen from (meth)acrylamides such as acrylamide, (meth)acrylic acids and their esters ((meth)acrylates) such as (2-hydroxyethyl acrylate). ), vinyl pyrrolidone, N-(C ₁ -C ₄ )alkylacrylamides, N,N-di(C ₁ -C ₄ )alkylacrylamide such as N,N-dimethyl acrylamide.

In this embodiment, the ethylenically unsaturated monomer not comprising a hydrophobic group is preferably N,N-dimethyl acrylamide.

Preferably, the AMPS® copolymer is a copolymer of 2-acrylamido-2-methylpropane sulfonic acid, preferably completely salified, preferably in the form of ammonium salt, and ethoxylated stearyl methacrylate (25OE).

As AMPS® copolymer, we can cite the copolymer marketed under the reference Aristoflex HMS by the company Clariant, with the name INCI Ammonium acryoyldimethyltaurate / steareth-25 methacrylate crosspolymer.

The AMPS® copolymer(s) described above may be present in the composition in a content ranging from 0.01 to 10% by weight, more preferably from 0.05 to 5% by weight and even more preferably from 0. 1 to 2% by weight relative to the total weight of the composition.

Emulsifying system

The composition according to the invention comprises an emulsifying system comprising at least one alkylpolyglucoside.

By “emulsifying system” is meant a system capable of forming an emulsion comprising surfactants.

For the purposes of the present invention, the term “alkylpolyglucoside” means an alkylmonooside (degree of polymerization 1) or alkylpolyoside (degree of polymerization greater than 1).

The alkylpolyglucoside(s) can be used alone or in the form of mixtures of several alkylpolyglucosides. They generally correspond to the following formula (IV):

(IV)

in which :
- the radical R ₁ designates a linear or branched alkyl radical comprising from 6 to 30 carbon atoms, preferably from 6 to 24 carbon atoms, more preferably from 8 to 22, and even more preferably from 12 to 20;
- group G is a saccharide residue;
- a is a number from 1 to 10.

As examples of alkylpolyglucosides, mention may be made of decyl glucoside, for example the product sold under the name Mydol 10® by the company Kao Chemicals or the product sold under the name Plantacare 2000 UP® by the company Henkel or the product marketed under the name ORAMIX NS 10® by the company SEPPIC; caprylyl/capryl glucoside such as the product marketed under the name Plantacare KE 3711® by the company Cognis or ORAMIX CG 110® by the company SEPPIC; laurylglucoside such as the product marketed under the name Plantacare 1200 UP® by the company Henkel or Plantaren 1200 N® by the company Henkel; cetearyl glucoside optionally mixed with cetostearyl alcohol, marketed for example under the name MONTANOV 68 by the company Seppic, under the name TEGO Care CG90 by the company Evonik Goldschmidt and under the names EMULGADE PL1618 or EMULGADE KE 3302 by the company Cognis ; arachidyl glucoside, for example in the form of the mixture of arachidyl and behenyl alcohols and arachidyl glucoside marketed under the name MONTANOV 202 by the company Seppic; cocoglucoside such as the product marketed under the name Plantacare 818 UP® by the company Henkel; or the product in the form of a mixture of cocoyl polyglucoside and cetyl and stearyl alcohols (35/65) marketed under the name MONTANOV 82 by the company Seppic; methyl coco glucoside marketed under the name Eumulgin GTS by the company Cognis; octyldodecyl xyloside marketed for example under the names FLUIDANOV 20X or EASYNOV by the company SEPPIC; caprylylglucoside such as the product marketed under the name Plantacare 810 UP® by the company Cognis; and their mixtures.

According to a preferred embodiment of the invention, the radical R ₁ designates a linear or branched alkyl radical comprising from 6 to 24 carbon atoms, preferably from 8 to 22, and even more preferably from 12 to 20.

According to another preferred embodiment of the invention, (G) _a is a glucoside group comprising from 1 to 5, in particular 1.2 to 3 glucoside units.

Preferably, the alkylpolyglucoside(s) correspond to the following formula (V):

(V)

in which :
- the radical R designates a linear or branched alkyl radical containing 12 to 22 carbon atoms;
- group G is a saccharide residue;
- x varies from 1 to 5, preferably from 1.05 to 2.5, and even more preferably from 1.1 to 2.

The remaining saccharide can be chosen from glucose, dextrose, sucrose, fructose, galactose, maltose, maltotriose, lactose, cellobiose, mannose, ribose, dextran, talose, allose, xylose, levoglucan, cellulose, starch and their mixtures. More preferably, the remainder of the saccharide is glucose.

It should also be noted that each unit of the polysaccharide part of the alkylpolyglucoside can be in α or β isomeric form, in L or D form and the configuration of the saccharide residue can be of the furanoside or pyranoside type.

It is of course possible to use mixtures of alkyl polysaccharides, which may differ from each other by the nature of the alkyl unit carried and/or the nature of the carrying polysaccharide chain.

According to a preferred embodiment of the invention, the alkylpolyglucoside can be used in mixture with at least one fatty alcohol, in particular a fatty alcohol having from 10 to 30 carbon atoms, and more particularly from 12 to 22 carbon atoms.

Furthermore, it is particularly advantageous, according to the present invention, to jointly use a fatty alcohol and an alkylpolyglucoside whose alkyl part is identical to that of the fatty alcohol retained.

Fatty alcohol/alkyl polyglucoside emulsifying mixtures as defined above are known as such. They are described in particular in applications WO 92/06778, WO 95/13863 and WO 98/47610 and prepared according to the preparation processes indicated in these documents.

Among the particularly preferred fatty alcohol/alkylpolyglucoside mixtures, we can cite the products sold by the company SEPPIC under the names MONTANOV® such as the following mixtures:
- Cetylstearyl alcohol/Cocoglucoside- MONTANOV 82®,
- Arachidyl alcohol and behenyl alcohol/arachidylglucoside- MONTANOV 202®,
- Myristyl alcohol/Myristylglucoside - MONTANOV 14®,
- Cetylstearyl alcohol/Cetylstearylglucoside – MONTANOV 68®
- C ₁₄ -C ₂₂ /C ₁₂ -C ₂₀ alkylglucoside alcohol - MONTANOV L®
- Cocoalcoholic/Coco-glucoside – MONTANOV S®
- Isostearyl alcohol/Isostearylglucoside - MONTANOV WO 18®.

Preferably, the alkylpolyglucoside(s) used in the composition according to the invention are chosen from cetylstearyl glucoside, arachidyl glucoside and their mixtures.

Preferably, the alkylpolyglucoside(s) used in the composition according to the invention are used in the form of a mixture with a fatty alcohol chosen from cetylstearyl alcohol (also called cetearyl alcohol), arachidyl alcohol, behenyl alcohol and mixtures thereof.

Preferably, the alkylpolyglucoside(s) are chosen from the arachidyl alcohol and behenyl alcohol/arachidylglucoside mixture, the cetylstearyl alcohol/cetylstearylglucoside mixture and their mixtures.

Preferably, the composition according to the invention comprises an emulsifying system comprising at least one alkylpolyglucoside chosen from the arachidyl alcohol and behenyl alcohol/arachidylglucoside mixture, the cetylstearyl alcohol/cetylstearylglucoside mixture and their mixtures.

We can cite the cetylstearyl alcohol/cetylstearylglucoside mixture, marketed by the company SEPPIC under the name MONTANOV 68®, consisting of approximately 20% cetylstearyl glucoside and approximately 80% cetylstearyl alcohol.

We can also cite the arachidyl alcohol and behenyl alcohol/arachidylglucoside mixture sold by the company SEPPIC under the name MONTANOV 202®.

The alkylpolyglucoside(s) may be present in the composition according to the invention in a content ranging from 0.01% to 15% by weight, preferably from 0.05% to 6% by weight relative to the total weight of the composition.

UV filters Organic UV filters

The compositions according to the invention contain one or more organic UV filters. These can be chosen from hydrophilic organic UV filters, lipophilic organic UV filters and insoluble organic UV filters.

By "hydrophilic UV filter" is meant any organic or inorganic cosmetic or dermatological compound filtering UV radiation capable of being completely dissolved in the molecular state in a liquid aqueous phase or of being solubilized in colloidal form (for example in the form micellar) in a liquid aqueous phase.

By "lipophilic filter" is meant any organic or inorganic cosmetic or dermatological compound filtering UV radiation capable of being completely dissolved in the molecular state in a liquid fatty phase or of being solubilized in colloidal form (for example in micellar form ) in a liquid fatty phase.

By “insoluble UV filter” is meant any organic or inorganic cosmetic or dermatological compound filtering UV radiation having a solubility in water of less than 0.5% by weight and a solubility of less than 0.5% by weight in most organic solvents such as paraffin oil, fatty alcohol benzoates and fatty acid triglycerides, for example Miglyol 812® marketed by the company DYNAMIT NOBEL. This solubility, achieved at 70°C, is defined as the quantity of product in solution in the solvent at equilibrium with an excess of solid in suspension after return to ambient temperature. It can easily be evaluated in the laboratory.

By “organic UVA filter” we mean any organic chemical molecule capable of absorbing at least UVA radiation in the wavelength range between 320 and 400 nm; said molecule can also absorb UVB radiation in the wavelength range between 280 and 320 nm.

By “organic UVB filter” we mean any organic chemical molecule capable of exclusively absorbing UVB radiation in the wavelength range between 280 and 320 nm.

Organic UV filters are chosen in particular from cinnamic compounds; anthranilate compounds; salicylic compounds; dibenzoylmethane compounds; benzylidene camphor compounds; benzophenone compounds; β,β-diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds, in particular those cited in patent US5624663; benzimidazole derivatives; imidazoline compounds; bis-benzoazolyl compounds as described in patents EP669323 and US 2,463,264; p-aminobenzoic compounds (PABA); methylene bis-(hydroxyphenyl benzotriazole) compounds as described in applications US5,237,071, US 5,166,355, GB2303549, DE 197 26 184 and EP893119; benzoxazole compounds as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; filter polymers and filter silicones such as those described in particular in application WO-93/04665; dimers derived from α-alkylstyrene such as those described in patent application DE19855649; 4,4-diarylbutadiene compounds as described in applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EP1133980 and EP133981 and their mixtures.

As examples of organic photoprotective agents, we can cite those designated below under their INCI name.

Cinnamic compounds:
Ethylhexyl Methoxycinnamate sold in particular under the trade name PARSOL MCX ® by DSM Nutritial Products,
Isopropyl Methoxycinnamate,
Isoamyl p-Methoxycinnamate sold under the trade name NEO HELIOPAN E 1000 ® by Symrise,
DEA Methoxycinnamate,
Diisopropyl Methylcinnamate,
Glyceryl Ethylhexanoate Dimethoxycinnamate.

Dibenzoylmethane compounds :
Butyl Methoxydibenzoylmethane sold in particular under the trade name PARSOL 1789 ® by DSM Nutritial Products,
Isopropyl Dibenzoylmethane.

Para-aminobenzoic compounds :
PABA,
Ethyl PABA,
Ethyl Dihydroxypropyl PABA,
Ethylhexyl Dimethyl PABA sold in particular under the name “ESCALOL 507®” by ISP,
Glyceryl PABA,
PEG-25 PABA sold under the name “UVINUL P 25®” by BASF.

Salicylic compounds:
Homosalate sold under the name “Eusolex HMS®” by Rona/EM Industries,
Ethylhexyl Salicylate sold under the name “NEO HELIOPAN OS®” by Symrise,
Dipropylene glycol Salicylate sold under the name “DIPSAL ®” by SCHER,
TEA Salicylate, sold under the name “NEO HELIOPAN TS®” by Symrise.

β,β - diphenyl acrylate compounds :
Octocrylene sold in particular under the trade name “UVINUL N 539®” by BASF,
Etocrylene, sold in particular under the trade name “UVINUL N 35®” by BASF.

Benzophenone compounds:
Benzophenone-1 sold under the trade name “UVINUL 400®” by BASF,
Benzophenone-2 sold under the trade name “UVINUL D 50®” by BASF,
Benzophenone-3 or Oxybenzone, sold under the trade name “UVINUL M 40®” by BASF,
Benzophenone-4 sold under the trade name “UVINUL MS 40®” by BASF,
Benzophenone-5,
Benzophenone-6 sold under the trade name “Helisorb 11®” by Norquay,
Benzophenone-8 sold under the trade name “Spectra-Sorb UV-24®” by American Cyanamid,
Benzophenone-9 sold under the trade name “UVINUL DS 49®” by BASF,
Benzophenone-12,
2-(4-diethylamino-2-hydroxybenzoyl)-n-hexyl benzoate sold under the trade name “UVINUL A Plus ®” or in mixture with octylmethoxycinnamate under the trade name “UVINUL A Plus B®” by the company BASF ,
1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone (CAS 919803-06-8) as described in application WO2007/ 071584; this compound being advantageously used in micronized form (average size of 0.02 to 2 µm) which can be obtained for example according to the micronization process described in applications GB-A-2 303 549 and EP-A-893119 and in particular in the form aqueous dispersion.

Benzylidene camphor compounds :
3-Benzylidene camphor manufactured under the name “MEXORYL SD®” by CHIMEX,
4-Methylbenzylidene camphor sold under the name “EUSOLEX 6300®” by MERCK,
Benzylidene Camphor Sulfonic Acid manufactured under the name “MEXORYL SL®” by CHIMEX,
Camphor Benzalkonium Methosulfate manufactured under the name “MEXORYL SO®” by CHIMEX,
Terephthalylidene Dicamphor Sulfonic Acid manufactured under the name “MEXORYL SX®” by CHIMEX,
Polyacrylamidomethyl Benzylidene Camphor manufactured under the name “MEXORYL SW®” by CHIMEX.

Compounds phenyl benzimidazole :
Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name “EUSOLEX 232®” by MERCK.

Bis- benzoazolyl compounds :
Disodium Phenyl Dibenzimidazole Tetra-sulfonate sold under the trade name “NEO HELIOPAN AP®” by Haarmann and REIMER.

Compounds phenyl benzotriazole :
Drometrizole Trisiloxane sold under the name “Silatrizole®” by RHODIA CHIMIE.

Methylene bis compounds -( hydroxyphenyl benzotriazole ):
Methylene bis-Benzotriazolyl Tetramethylbutylphenol in particular in solid form such as the product sold under the trade name “MIXXIM BB/100 ®” by FAIRMOUNT CHEMICAL or in the form of an aqueous dispersion of micronized particles having an average particle size which varies from 0.01 to 5 μm and more preferably from 0.01 to 2 μm and more particularly from 0.020 to 2 μm with at least one alkylpolyglycoside surfactant of structure C_notH_2n+1O(C₆H₁₀O₅)_xH in which n is an integer from 8 to 16 and x is the average degree of polymerization of the unit (C₆H₁₀O₅) and varies from 1.4 to 1.6 as described in patent GB-A-2 303 549 in particular sold under the trade name “TINOSORB M®” by BASF or in the form of an aqueous dispersion of micronized particles having an average particle size which varies from 0.02 to 2 μm and more preferably from 0.01 to 1.5 μm and more particularly from 0.02 to 1 μm in the presence of at least one mono-(C₈-VS₂₀) polyglycerol alkyl ester having a degree of glycerol polymerization of at least 5 such as the aqueous dispersions described in application WO2009/063392.

Triazine compounds:
- 3,3'-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine), INCI name Phenylene Bis-Diphenyl triazine, with the following chemical formula: - Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name “TINOSORB S®” by BASF,
- Ethylhexyl Triazone sold in particular under the trade name “UVINUL T 150®” by BASF,
- Diethylhexyl Butamido Triazone sold under the trade name “UVASORB HEB ®” by SIGMA 3V,
- dineopentyl 2,4,6-tris-(4'-amino benzalmalonate)-s-triazine,
- diisobutyl 2,4,6-tris-(4'-amino benzalmalonate)-s-triazine,
- n-butyl 2,4-bis-(4'-aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine,
- dineopentyl 2,4-bis-(4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine,
- symmetrical triazine filters substituted with naphthalenyl groups or polyphenyl groups described in patent US6,225,467, application WO2004/085412 (see compounds 6 and 9) or the document “Symetrical Triazine Derivatives” IP.COM IPCOM000031257 Journal, INC WEST HENRIETTA, NY, US (September 20, 2004) in particular 2,4,6-tris(di-phenyl)-triazine and 2,4,6-tris(ter-phenyl)-triazine which is included in the patent applications WO06/035000, WO06/034982, WO06/034991, WO06/035007, WO2006/034992, WO2006/034985, these compounds being used advantageously in micronized form (average particle size of 0.02 to 3 µm) which can be obtained for example according to the micronization process described in applications GB-A-2 303 549 and EP-A-893119 and in particular in aqueous dispersion form,
- triazine silicones substituted by two aminobenzoate groups as described in patent EP0841341 in particular 2,4-bis-(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3- tetramethyl-1-[(trimethyl¬silyl¬oxy]-disiloxanyl}propyl)amino]-s-triazine.

Anthranilic compounds :
Menthyl anthranilate sold under the commercial trade name “NEO HELIOPAN MA®” by Symrise.

Imidazoline compounds:
Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate.

Benzalmalonate compounds :
Polyorganosiloxane with benzalmalonate functions such as Polysilicone-15 sold under the trade name “PARSOL SLX ®” by HOFFMANN LA ROCHE.

4,4-diarylbutadiene compounds:
1,1-dicarboxy (2,2'-dimethyl-propyl)-4,4-diphenylbutadiene.

Benzoxazole compounds :
2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine sold under the name Uvasorb K2A® by Sigma 3V.

Preferential organic filters are chosen from:
Ethylhexyl Methoxycinnamate,
Ethylhexyl Salicylate,
Homosalate,
Butyl Methoxydibenzoylmethane,
Octocrylene,
Phenylbenzimidazole Sulfonic Acid,
Benzophenone-3,
Benzophenone-4,
Benzophenone-5,
n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)-benzoate,
4-Methylbenzylidene camphor,
Terephthalylidene Dicamphor Sulfonic Acid,
Disodium Phenyl Dibenzimidazole Tetra-sulfonate,
Methylene bis-Benzotriazolyl Tetramethylbutylphenol,
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine
Ethylhexyl Triazone,
Diethylhexyl Butamido Triazone,
2,4,6-tris-(4'-amino dineopentyl benzalmalonate)-s-triazine,
2,4,6-tris-(4'-amino diisobutyl benzalmalonate)-s-triazine,
2,4-bis-(n-butyl 4'-aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine,
2,4-bis-(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine,
2,4-bis-(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3-tetramethyl-1-[(trimethylsilyl-oxy]disiloxanyl}propyl)amino]-s- triazine,
2,4,6-tris-(di-phenyl)-triazine,
2,4,6-tris-(ter-phenyl)-triazine
Drometrizole Trisiloxane,
Polysilicone-15,
1,1-dicarboxy (2,2'-dimethyl-propyl)-4,4-diphenylbutadiene,
2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine,
and their mixtures.

Particularly preferred organic filters are chosen from:
Ethylhexyl Salicylate,
Homosalate,
Butyl Methoxydibenzoylmethane,
Octocrylene,
n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)-benzoate,
Phenylbenzimidazole Sulfonic Acid,
Terephthalylidene Dicamphor Sulfonic Acid,
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine,
Ethylhexyl Triazone,
Diethylhexyl Butamido Triazone,
2,4-bis-(n-butyl 4'-aminobenzalmalonate)-6-[(3-{1,3,3,3-tetramethyl-1-[(trimethylsilyl-oxy]disiloxanyl}propyl)amino]-s- triazine,
Drometrizole Trisiloxane,
and their mixtures.

According to a preferred embodiment, the organic UV filters are chosen from:
Ethylhexyl Salicylate,
Butyl Methoxydibenzoylmethane,
Phenylbenzimidazole Sulfonic Acid,
Ethylhexyl Triazone,
Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine,
and their mixtures.

According to a particular embodiment of the invention, the composition is free of octocrylene. The term “free from octocrylene” means a composition containing less than 1% by weight, or even less than 0.5% by weight, relative to the total weight of the composition, of octocrylene. Octocrylene could in fact be used in the past both as a sunscreen but also as a solvent to improve the solubility of other sunscreens such as triazine derivatives, and thus reduce the stickiness of compositions comprising such filters. However, there is a consumer expectation for cosmetic compositions comprising sun filters, having good sensoriality, non-sticky, but devoid of octocrylene.

The organic UV filters may be present in the composition according to the invention at a content ranging from 0.05% to 20% by weight, preferably from 0.1% to 15% by weight, and even more preferably from 0.5 % to 10% by weight relative to the total weight of the composition.

Additional UV filters

The composition according to the invention may also comprise at least one inorganic UV filter.

The inorganic UV filters used in accordance with the present invention are metal oxide pigments. More preferably, the inorganic UV filters of the invention are metal oxide particles having an average elementary particle size less than or equal to 0.5 µm, more preferably between 0.005 and 0.5 µm, and even more preferably between 0.005 and 0.5 µm. between 0.01 and 0.2 µm, even better between 0.01 and 0.1 µm, and more particularly between 0.015 and 0.05 µm.

They may in particular be chosen from oxides of titanium, zinc, iron, zirconium, cerium or mixtures thereof.

Such metal oxide pigments, coated or uncoated, are in particular described in patent application EP-A-0 518 773. As commercial pigments, mention may be made of the products sold by the companies SACHTLEBEN PIGMENTS, TAYCA, MERCK AND DEGUSSA.

Metal oxide pigments can be coated or uncoated.

Coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and/or mechanical nature with compounds such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin) , alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.

The coated pigments are more particularly coated titanium oxides:
- silica such as the products “SUNVEIL®” from the company IKEDA, “SUNSIL TIN 50” from the company SUNJIN BEAUTY SCIENCE,
- silica and iron oxide such as the product “SUNVEIL F®” from the company IKEDA,
- silica and alumina such as the products "MICROTITANIUM DIOXIDE MT 500 SA®" and "MICROTITANIUM DIOXIDE MT 100 SA" from the company TAYCA, "TIOVEIL" from the company TIOXIDE,
- alumina such as the products “TIPAQUE TTO-55 (B)®” and “TIPAQUE TTO-55 (A)®” from the company ISHIHARA, and “UVT 14/4” from the company SACHTLEBEN PIGMENTS,
- alumina and aluminum stearate such as the products "MICROTITANIUM DIOXIDE MT 100 T®, MT 100 TX®, MT 100 Z®, MT-01®" from the company TAYCA, the products "Solaveil CT-10 W ®" and "Solaveil CT 100®" from the company UNIQEMA and the product "Eusolex T-AVO®" from the company MERCK,
- silica, alumina and alginic acid such as the product “MT-100 AQ®” from the company TAYCA,
- alumina and aluminum laurate such as the product “MICROTITANIUM DIOXIDE MT 100 S®” from the company TAYCA,

- iron oxide and iron stearate such as the product “MICROTITANIUM DIOXIDE MT 100 F®” from the company TAYCA,
- zinc oxide and zinc stearate such as the product "BR 351®" from the company TAYCA,
- silica and alumina and treated with a silicone such as the products "MICROTITANIUM DIOXIDE MT 600 SAS®", "MICROTITANIUM DIOXIDE MT 500 SAS®" or "MICROTITANIUM DIOXIDE MT 100 SAS®" from the company TAYCA,
- silica, alumina, aluminum stearate and treated with a silicone such as the product "STT-30-DS®" from the company TITAN KOGYO,
- silica and treated with a silicone such as the product "UV-TITAN X 195®" from the company SACHTLEBEN PIGMENTS,
- alumina and treated with a silicone such as the products "TIPAQUE TTO-55 (S)®" from the company ISHIHARA, or "UV TITAN M 262®" from the company SACHTLEBEN PIGMENTS,
- triethanolamine such as the product “STT-65-S” from the company TITAN KOGYO,
- stearic acid such as the product “TIPAQUE TTO-55 (C)®” from the company ISHIHARA,
- sodium hexametaphosphate such as the product “MICROTITANIUM DIOXIDE MT 150 W®” from the company TAYCA,
- TiO2 treated with octyl trimethyl silane sold under the trade name “T 805®” by the company DEGUSSA SILICES,
- TiO2 treated with a polydimethylsiloxane sold under the trade name “70250 Cardre UF TiO2SI3®” by the company CARDRE,
- anatase/rutile TiO2 treated with a polydimethylhydrogensiloxane sold under the trade name "MICRO TITANIUM DIOXIDE USP GRADE HYDROPHOBIC®" by the company COLOR TECHNIQUES,
- TiO2 coated with triethylhexanoin, aluminum stearate, alumina sold under the trade name Solaveil CT-200-LQ-(WD) from CRODA,
- TiO2 coated with aluminum stearate, alumina and silicone sold under the trade name Solaveil CT-12W-LQ-(WD from CRODA),
- TiO2 coated with lauroyl lysine sold by Daito Kasei Kogyo under the name LL 5 Titanium Dioxide CR 50,
- TiO2 coated with C9-15 fluoroalcohol phosphate and aluminum hydroxide sold by Daito Kasei Kogyo under the name PFX-5 TiO2 CR-50.

We can also cite TiO2 pigments doped with at least one transition metal such as iron, zinc, manganese and more particularly manganese. Preferably, said doped pigments are in the form of an oily dispersion. The oil present in the oily dispersion is preferably chosen from triglycerides including those of capric/caprylic acids. The oily dispersion of titanium oxide particles may additionally comprise one or more dispersing agents such as for example a sorbitan ester such as sorbitan isostearate, an ester of fatty acid and polyoxyalkylenated glycerol such as TRI-PPG3 MYRISTYLETHER CITRATE and POLYGLYCERYL-3 POLYRICINOLEATE. Preferably, the oily dispersion of titanium oxide particles comprises at least one dispersing agent chosen from fatty acid esters and polyoxyalkylenated glycerol. Mention may be made more particularly of the oily dispersion of TiO2 particles doped with manganese in capric/caprylic acid triglyceride in the presence of TRI-PPG-3 MYRISTYLETHER CITRATE and POLYGLYCERYL-3-POLYRICINOLEATE and SORBITAN ISOSTERATE of INCI name: TITANIUM DIOXIDE (and) TRI-PPG-3 MYRISTYLETHER CITRATE (and) POLYGLYCERYL-3 RICINOLEATE (and) SORBITAN ISOSTEARATE like the product sold under the trade name OPTISOL TD50 ® by the company CRODA.

Uncoated titanium oxide pigments are for example sold by the company TAYCA under the trade names "MICROTITANIUM DIOXIDE MT 500 B" or "MICROTITANIUM DIOXIDE MT600 B®", by the company DEGUSSA under the name "P 25", by the company WACKHER under the name "Transparent titanium oxide PW®", by the company MIYOSHI KASEI under the name "UFTR®", by the company TOMEN under the name "ITS®" and by the company TIOXIDE under the name "TIOVEIL AQ ".

Uncoated zinc oxide pigments are, for example:
- those marketed under the name “Z-cote” by the company Sunsmart;
- those marketed under the name “Nanox®” by the company Elementis;
- those marketed under the name “Nanogard WCD 2025®” by the company Nanophase Technologies.

Coated zinc oxide pigments are for example:
- those marketed under the name “Zinc Oxide CS-5®” by the company Toshibi (ZnO coated with polymethylhydrogensiloxane);
- those marketed under the name "Nanogard Zinc Oxide FN®" by the company Nanophase Technologies (dispersed at 40% in Finsolv TN®, C ₁₂ -C ₁₅ alcohol benzoate);
- those marketed under the name "DAITOPERSION Zn-30®" and "DAITOPERSION Zn-50®" by the company Daito (dispersions in oxyethylenated cyclopolymethylsiloxane/polydimethylsiloxane, containing 30% or 50% of zinc oxides coated with silica and polymethylhydrogensiloxane);
- those marketed under the name “NFD Ultrafine ZnO®” by the company Daikin (ZnO coated with perfluoroalkyl phosphate and perfluoroalkylethyl-based copolymer dispersed in cyclopentasiloxane);
- those marketed under the name "SPD-Z1®" by the company Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane);
- those marketed under the name "Escalol Z100®" by the company ISP (ZnO treated with alumina and dispersed in the ethylhexyl methoxycinnamate/PVP-hexadecene/methicone copolymer mixture);
- those marketed under the name "Fuji ZnO-SMS-10®" by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane);
- those marketed under the name "Nanox Gel TN®" by the company Elementis (ZnO dispersed at 55% in C ₁₂ -C ₁₅ alcohol benzoate with hydroxystearic acid polycondensate).

Uncoated cerium oxide pigments can for example be those sold under the name “COLLOIDAL CERIUM OXIDE®” by the company RHONE POULENC.

Uncoated iron oxide pigments are for example sold by the company ARNAUD under the names “NANOGARD WCD 2002® (FE 45B®)”, “NANOGARD IRON FE 45 BL AQ”, “NANOGARD FE 45R AQ®”, “NANOGARD WCD 2006 ® (FE 45R®)", or by the MITSUBISHI company under the name "TY-220®".

Coated iron oxide pigments are for example sold by the company ARNAUD under the names "NANOGARD WCD 2008 (FE 45B FN)®", "NANOGARD WCD 2009® (FE 45B 556®)", "NANOGARD FE 45 BL 345 ®", "NANOGARD FE 45 BL®", or by the company BASF under the name "TRANSPARENT IRON OXIDE®".

We can also cite mixtures of metal oxides, in particular titanium dioxide and cerium dioxide, including the equal weight mixture of titanium dioxide and cerium dioxide coated with silica, sold by the company IKEDA under the name "SUNVEIL A ®", as well as the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone such as the product "M 261®" sold by the company SACHTLEBEN PIGMENTS or coated with alumina, silica and glycerin such as the product “M 211®” sold by the company SACHTLEBEN PIGMENTS.

According to the invention, titanium oxide pigments, coated or uncoated, are particularly preferred.
When they are present in the composition according to the invention, the mineral UV filters are advantageously present at a content ranging from 0.05% to 10% by weight, preferably from 0.1% to 5% by weight, and even more preferably from 0.5% to 3% by weight relative to the total weight of the composition.

Aqueous phase

The composition according to the invention comprises at least one aqueous phase.

The aqueous phase contains water, and optionally other organic solvents soluble or miscible in water.

An aqueous phase suitable for the invention may comprise, for example, water chosen from natural spring water, such as water from La Roche-Posay, water from Vittel, water from Saint Gervais Mont Blanc, or Vichy waters, or floral water.

The water-soluble or miscible solvents suitable for the invention include, in addition to short-chain alcohols, diols or polyols such as ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol, hexylene glycol, diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether, glycerol, and sorbitol, and mixtures thereof.

According to a particular embodiment of the invention, the composition comprises a quantity of glycerin less than 10%, preferably less than 5%, by weight of the total weight of the composition.

According to a particular form of the invention, the overall aqueous phase, including all the hydrophilic substances of the composition capable of being solubilized in this same phase, represents from 20 to 95% by weight, and preferably from 30 to 80% by weight. weight relative to the total weight of the composition.

Oily phase

The composition according to the invention comprises at least one oily phase.

For the purposes of the invention, the term “oily phase” means a phase comprising at least one oil and all of the liposoluble and lipophilic ingredients and fatty substances used for the formulation of the compositions of the invention.

By oil we mean any fatty substance in liquid form at room temperature (20 – 25 °C) and at atmospheric pressure (760 mm Hg).

The oily phase may comprise, in addition to the lipophilic filter(s) and the fatty alcohol(s) according to the invention, at least one volatile or non-volatile hydrocarbon oil and/or a volatile and or non-volatile silicone oil and/or a fluorinated oil. volatile and or non-volatile.

For the purposes of the present invention, the term “silicone oil” means an oil comprising at least one silicon atom, and in particular at least one Si-O group.

The term “hydrocarbon oil” means an oil containing mainly hydrogen and carbon atoms and possibly one or more heteroatoms, in particular nitrogen and oxygen. Thus these oils may in particular contain one or more carboxy, ester, ether or hydroxy functions.

The term “fluorinated oil” means an oil comprising at least one fluorine atom.

For the purposes of the invention, the term “volatile oil” means an oil capable of evaporating on contact with the skin or the keratin fiber in less than an hour, at room temperature and atmospheric pressure. The volatile oil(s) of the invention are volatile cosmetic oils, liquid at room temperature, having a non-zero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40,000 Pa (10 ^{- 3} to 300 mm Hg), in particular ranging from 1.3 Pa to 13,000 Pa (0.01 to 100 mm Hg), and more particularly ranging from 1.3 Pa to 1300 Pa (0.01 to 10 mm of Hg).

By "non-volatile oil" is meant an oil remaining on the skin or keratin fiber at room temperature and atmospheric pressure for at least several hours and in particular having a vapor pressure less than 10 ^-3 mm Hg (0.13 Pa) .

As non-volatile hydrocarbon oils which can be used according to the invention, the following may be cited in particular:
(i) hydrocarbon oils of plant origin such as glyceride triesters which are generally triesters of fatty acids and glycerol whose fatty acids can have chain lengths varying from C ₄ to C ₂₄ , the latter being able to be linear or branched, saturated or unsaturated; these oils are in particular wheat germ, sunflower, grape seed, sesame, corn, apricot, castor, shea, avocado, olive, soybean oil. sweet almond, palm, rapeseed, cotton, hazelnut, macadamia, jojoba, alfalfa, poppy, pumpkin, sesame, squash, rapeseed, blackcurrant, evening primrose, millet, barley, quinoa, rye, safflower, cancholy, passionflower, muscat rose; or even the triglycerides of caprylic/capric acids such as those sold by the company Stéarineries Dubois or those sold under the names Miglyol 810®, 812® and 818® by the company Dynamit Nobel;
(ii) synthetic ethers having 10 to 40 carbon atoms;
(iii) linear or branched hydrocarbons, of mineral or synthetic origin such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as parulam, squalane, and their mixtures;
(iv) synthetic esters such as oils of formula RCOOR' in which R represents the remainder of a linear or branched fatty acid comprising from 1 to 40 carbon atoms and R' represents a hydrocarbon chain in particular branched containing from 1 to 40 carbon atoms provided that R + R' is ≥ 10, such as for example Purcellin oil (cetostearyl octanoate), isopropyl myristate, isopropyl palmitate, C ₁₂ -C alcohol benzoate ₁₅ like the product sold under the trade name “Finsolv TN®” or “Witconol TN®” by the company WITCO or “TEGOSOFT TN ®” by the company EVONIK GOLDSCHMIDT, 2-ethylphenyl benzoate like the commercial product sold under the name “X-TEND 226®” by the company ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethyl palmitate -hexyl, isostearyl isostearate, diisopropyl sebacate such as the product sold under the name “Dub Dis” by the company Stearinerie Dubois, isopropyl isostearate such as the product sold under the name Jolee 7739 by the OLEON company; octanoates, decanoates or ricinoleates of alcohols or polyalcohols such as propylene glycol dioctanoate; hydroxylated esters such as isostearyl lactate, di-isostearyl malate; and pentaerythritol esters; citrates or tartrates such as linear C ₁₂ -C ₁₃ di-alkyl tartrates such as those sold under the name COSMACOL ETI® by the Company ENICHEM AUGUSTA INDUSTRIALE as well as linear C ₁₄ -C ₁₅ di-alkyl tartrates such than those sold under the name COSMACOL ETL® by the same company; acetates;
(v) fatty alcohols that are liquid at room temperature with a branched and/or unsaturated carbon chain having 12 to 26 carbon atoms such as octyl dodecanol, isostearyl alcohol, oleic alcohol, 2-hexyldecanol, 2- butyloctanol, 2-undecylpentadecanol;
(vi) higher C ₁₂ -C ₂₂ fatty acids, such as oleic acid, linoleic acid, linolenic acid;
(vii) carbonates such as dicaprylyl carbonate such as the product sold under the name “Cetiol CC®” by the company Cognis;
and their mixtures.

Among the non-volatile hydrocarbon oils which can be used according to the invention, glyceride triesters and in particular caprylic/capric acid triglycerides, synthetic esters and in particular isopropyl isostearate, diisopropyl adipate, diisopropyl sebacate will be more particularly preferred. , isopropyl palmitate, dicaprylyl carbonate, isononyl isononanoate, oleyl erucate, C ₁₂ -C ₁₅ alcohol benzoate, 2-ethylphenyl benzoate and fatty alcohols in particular octyldodecanol .

As volatile hydrocarbon oils which can be used according to the invention, mention may in particular be made of hydrocarbon oils having 8 to 16 carbon atoms, and in particular branched C ₈ -C ₁₆ alkanes such as C ₈ -C ₁₆ isoalkanes of petroleum origin. (also called isoparaffins) such as isododecane (also called 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, oils sold under the trade names Isopars or Permetyls, esters branched in C ₈ -C ₁₆ , iso-hexyl neopentanoate, and mixtures thereof.

We can also cite the alkanes described in the patent applications of the company Cognis WO 2007/068371, or WO2008/155059 (mixtures of distinct alkanes different from at least one carbon). These alkanes are obtained from fatty alcohols, themselves obtained from coconut or palm oil. we can cite the mixtures of n-undecane (C ₁₁ ) and n-tridecane (C ₁₃ ) obtained in Examples 1 and 2 of application WO2008/155059 from the Cognis Company. We can also cite n-dodecane (C ₁₂ ) and n-tetradecane (C ₁₄ ) sold by Sasol respectively under the references PARAFOL 12-97 and PARAFOL 14-97®, as well as their mixtures.

Other volatile hydrocarbon oils such as petroleum distillates, in particular those sold under the name Shell Solt® by the company SHELL, can also be used. According to one embodiment, the volatile solvent is chosen from volatile hydrocarbon oils having 8 to 16 carbon atoms and their mixtures.

The non-volatile silicone oils can be chosen in particular from non-volatile polydimethylsiloxanes (PDMS), polydimethylsiloxanes comprising alkyl or alkoxy groups, during and/or at the end of the silicone chain, groups each having from 2 to 24 carbon atoms, silicones phenyls such as phenyl trimethicones, phenyl dimethicones, phenyl trimethylsiloxy diphenylsiloxanes, diphenyl dimethicones, diphenyl methyldiphenyl trisiloxanes, 2-phenylethyl trimethylsiloxysilicates.

As volatile silicone oils, mention may be made, for example, of linear or cyclic volatile silicone oils, in particular those having a viscosity ≤ 8 centistokes (8.10 ^-6 m ² /s), and having in particular from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having 1 to 10 carbon atoms. As volatile silicone oil which can be used in the invention, mention may be made in particular of octamethyl cyclotetrasiloxane, decamethyl cyclopentasiloxane, dodecamethyl cyclohexasiloxane, heptamethyl hexyltrisiloxane, heptamethyloctyl trisiloxane, hexamethyl disiloxane, octamethyl trisiloxane, decamethyl tetrasiloxane, dodecamethyl pentasiloxane and mixtures thereof.

We can also cite volatile linear alkyltrisiloxane oils of the following formula:
where R represents an alkyl group comprising 2 to 4 carbon atoms and one or more hydrogen atoms of which may be substituted by a fluorine or chlorine atom.

Among the formula 8 oils, we can cite:
3-butyl 1,1,1,3,5,5,5-heptamethyl trisiloxane,
3-propyl 1,1,1,3,5,5,5-heptamethyl trisiloxane, and
3-ethyl 1,1,1,3,5,5,5-heptamethyl trisiloxane,
corresponding to the oils of formula 8 for which R is respectively a butyl group, a propyl group or an ethyl group.

Fluorinated volatile oils can also be used, such as nonafluoromethoxybutane, nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane and mixtures thereof.

An oily phase according to the invention may further comprise, mixed with or solubilized in the oil, other fatty substances.

Another fatty substance which may be present in the oily phase may be, for example:
- a fatty acid chosen from fatty acids containing 8 to 30 carbon atoms, such as stearic acid, lauric acid, palmitic acid and oleic acid;
- a wax chosen from waxes such as lanolin, beeswax, Carnauba or Candellila wax, rice bran wax, paraffin waxes, lignite waxes or microcrystalline waxes, ceresin or ozokerite , synthetic waxes such as polyethylene waxes, Fischer-Tropsch waxes;
- a gum chosen from silicone gums (dimethiconol),
- a pasty compound, such as polymeric or non-polymeric silicone compounds, esters of an oligomeric glycerol, arachidyl propionate, triglycerides of fatty acids and their derivatives,
- and their mixtures.

Preferably, the overall oily phase, including all the lipophilic substances of the composition capable of being solubilized in this same phase, including the lipophilic filters, represents 5 to 95% by weight, and preferably 10 to 50%. in weight relative to the total weight of the composition.

The composition according to the invention comprises isopropyl myristate, in a content ranging from 0.01% to 10% by weight, preferably from 0.1% to 5%, preferably from 0.5 to 4% by weight. weight relative to the total weight of the composition.

In a particular embodiment, the composition according to the invention further comprises at least one synthetic ester chosen from isopropyl isostearate, isopropyl palmitate, isononyl isononanoate, isostearyl isostearate and diisopropyl sebacate. Said at least one synthetic ester is then present in the composition in a content ranging from 0.01% to 10% by weight, preferably from 0.1% to 5%, preferably from 0.5 to 4% by weight. weight relative to the total weight of the composition.

Cross-linked (meth)acrylic acid homopolymer

The composition according to the invention may also comprise at least one crosslinked (meth)acrylic acid homopolymer, different from the AMPS® copolymer previously described.

Preferably, the composition according to the invention comprises at least one crosslinked (meth)acrylic acid homopolymer.

The homopolymer can be crosslinked with a crosslinking agent, in particular chosen from pentaerythritol allyl ether, sucrose allyl ether, or propylene allyl ether.

As an example, we can cite those sold by the company Lubrizol under the names Carbopol, 910, 934, 940, 941, 934 P, 980, 981, 2984, 5984, Carbopol Ultrez 10 Polymer (INCI name: carbomer), or by the company 3V-Sigma under the name Synthalen®K, Synthalen®L, or Synthalen®M.

The crosslinked (meth)acrylic acid homopolymer(s), different from the AMPS® copolymer previously described, may be present in the composition according to the invention in a content ranging from 0.01% to 5% by weight, preferably from 0.1% to 2% by weight relative to the total weight of the composition.
AMPS® homopolymer ( poly( 2-acrylamido 2-methyl propane sulfonic acid))

The composition of the invention may also comprise at least one crosslinked or non-crosslinked homopolymer comprising 2-acrylamido 2-methyl propane sulfonic acid (AMPS®) units, different from the AMPS® copolymer previously described.

The 2-acrylamido 2-methyl propane sulfonic acid homopolymer may be cross-linked or non-cross-linked.

These are water-soluble, water-dispersible or water-swellable copolymers.

Preferably, the AMPS® homopolymers used in accordance with the invention can be partially or completely neutralized with an inorganic base (such as sodium hydroxide, potassium hydroxide or aqueous ammonia) or an organic base such as mono-, di- or triethanolamine, aminomethylpropanediol, N-methylglucamine or basic amino acids such as arginine and lysine, and mixtures of these compounds. They are generally neutralized. In the present invention, the term "neutralized" is understood to mean polymers which have been completely or almost completely neutralized, i.e. neutralized by at least 90%.

The AMPS® homopolymers used in the composition of the invention generally have a number average molecular mass ranging from 1000 to

20,000,000 g/mol, preferably ranging from 20,000 to 5,000,000, and even more preferably from 100,000 to 1,500,000 g/mol.

When the homopolymers are crosslinked, the crosslinking agents can be chosen from compounds having an olefinic polyunsaturation commonly used to crosslink polymers obtained by radical polymerization. As crosslinking agents, mention may, for example, be made of divinylbenzene, diallyl ether, dipropylene glycol diallyl ether, polyglycol diallyl ethers, triethylene glycol divinyl ether, hydroquinone diallyl ether, ethylene glycol di(meth)acrylate, di(meth) )tetraethylene glycol acrylate, trimethylolpropane triacrylate, methylenebisacrylamide, methylenebismethacrylamide, triallylamine, triallyl cyanurate, diallyl maleate, tetraallylethylenediamine, tetraallyloxyethane, trimethylolpropane diallyl ether, allyl (meth)acrylate, allyl alcohol ethers of the series sugars, or other allyl or vinyl ethers of polyfunctional alcohols, and also allyl esters of phosphoric acid derivatives and/or vinyl phosphonic acid derivatives, or mixtures of these compounds.

The degree of crosslinking generally ranges from 0.01 to 10 mol%, and more particularly from 0.2 to 2 mol%, relative to the polymer.

In a particular embodiment, a preferred polymer of the present invention is poly(2-acrylamido 2-methyl propane sulfonic acid), which is partially neutralized with ammonia and highly crosslinked, such as polyacryloyldimethyl ammonium taurate , also known under the trade name Hostacerin AMPS®, and commercially available from the supplier Clariant.

Preferably, the composition of the invention comprises poly(2-acrylamido 2-methyl propane sulfonic acid).

The AMPS® homopolymer according to the invention is generally present in quantities of active material ranging from 0.01 to 20% by weight, more preferably from 0.1 to 10% by weight, even more preferably from 0.5 to 5% by weight and more particularly from 0.8 to 3% by weight relative to the total weight of the composition.

Acyl glutamic acids and their salts

The composition according to the invention may also comprise at least one acyl glutamic acid (INCI name: acyl glutamic acid) or one of its salts (acyl glutamates).

Preferably, the acyl glutamic acid(s) are chosen from acyl glutamic acids whose acyl group comprises from 10 to 30 carbon atoms, preferably from 12 to 22 carbon atoms, such as for example lauroyl glutamic acid, myristoyl glutamic acid, palmitoyl glutamic acid, stearoyl glutamic acid, behenoyl glutamic acid, olivoyl glutamic acid, cocoyl glutamic acid and the salts of these acids, in particular the salts of alkali metals such as Na, Li, K, preferably Na or K, the salts of alkaline earth metals such as Mg or the ammonium salts of said acids.

Preferably, the acyl glutamic acid(s) or one of its salts are chosen from lauroyl glutamic acids, cocoyl glutamic acids, sodium stearoyl glutamate, potassium lauroyl glutamate, potassium cocoyl glutamate, sodium olivoyl glutamate and their mixtures.

More preferably, acyl glutamic acid or one of its salts is sodium stearoyl glutamate (INCI name).

Such compounds are marketed under the name AMISOFT by the company AJINOMOTO and in particular under the references Amisoft CA, Amisoft LA, Amisoft HS 11 PF, Amisoft MK-11, Amisoft LK-11, Amisoft CK-11, or even under the name EUMULGIN SG by the company COGNIS.

We can also cite triethanolamine cocoyl glutamate marketed under the name AMISOFT CT 12 by the company AJINOMOTO and triethanolamine lauroyl glutamate marketed under the name ACYLGLUTAMATE LT-12 by the company AJINOMOTO.

As an acyl glutamic acid salt, mention may also be made of sodium hydrogenated tallowoyl glutamate such as that marketed under the reference ACYLGLUTAMATE HS 11 by the company AJINOMOTO and disodium hydrogenated tallow glutamate such as that marketed under the reference ACYLGLUTAMATE HS-21 by the company AJINOMOTO. AJINOMOTO company.

Mention may also be made of commercial mixtures of surfactants comprising at least one glutamic acid derivative or a salt of said derivative, such as for example the mixture of acyl glutamate salts such as Amisoft LS-22 marketed by AJINOMOTO.

According to a preferred embodiment of the invention, the monosodium salt of n-stearoyl-L-glutamic acid is used (INCI name: sodium stearoyl glutamate) such as that marketed by the company AJINOMOTO under the reference AMISOFT HS 11 PF .

According to another preferred embodiment of the invention, the disodium salt of n-stearoyl-L-glutamic acid is used (INCI name: disodium stearoyl glutamate) such as that marketed by the company AJINOMOTO under the reference AMISOFT HS 21 P.

The acyl glutamic acid(s) and their salts may be present in the composition in a content ranging from 0.01% to 5% by weight, preferably from 0.05% to 2% by weight, more preferably 0.1%. at 1% by weight relative to the total weight of the composition.
Alkyl- and polyalkyl -esters of poly( ethylene oxide )

According to a preferred embodiment, the compositions of the invention may also comprise at least one nonionic surfactant, chosen from poly(ethylene oxide) alkyl- and polyalkyl-esters.

We preferably use those having a number of ethylene oxide units (0E) ranging from 2 to 200. We can for example cite the stearate product PEG-8, which is marketed under the trade name Myrj S8 SO by the company Croda, stearate 40 0E, stearate 50 0E, stearate 100 0E, laurate 20 0E, laurate 40 0E, distearate 150 0E.

In a preferred embodiment, the compositions of the invention may comprise the stearate product PEG-100, marketed under the trade name Myrj S 100 MBAL-PA by the company CRODA.

The poly(ethylene oxide) alkyl- and polyalkyl esters may be present in the composition in a content ranging from 0.01% to 5% by weight, preferably from 0.05% to 2% by weight. , more preferably from 0.1% to 1% by weight relative to the total weight of the composition.

Additives

The composition according to the invention may further comprise cosmetic adjuvants chosen from deodorant active ingredients, desquamating agents, antimicrobial agents, moisturizing agents, soothing agents, antioxidant agents, astringent agents, anti-aging agents, anti-wrinkle agents; softeners, antioxidants, stabilizers, vitamins, bactericides, preservatives, dyes, perfumes or any other ingredient usually used in cosmetics for this type of application, and their mixtures.

Of course, those skilled in the art will take care to choose this or these possible complementary compounds in such a way that the advantageous properties intrinsically attached to the cosmetic composition in accordance with the invention are not, or substantially not, altered by the addition(s) envisaged. .

Galenic

The compositions according to the invention can be prepared according to techniques well known to those skilled in the art. They can be presented in particular in the form of an emulsion, simple or complex (O/W, W/O, O/W/O or W/O/W) such as a cream, a milk or a cream gel. .

According to a particular embodiment of the invention, the composition is in the form of an emulsion. It can in particular be in the form of an oil-in-water emulsion (direct emulsion) or in the form of a water-in-oil emulsion (inverse emulsion). Preferably, the composition is in the form of an oil-in-water emulsion.

In the case of compositions in the form of oil-in-water or water-in-oil emulsions, the emulsification processes that can be used are pale or propeller, rotor-stator and HHP type.

A person skilled in the art will be able to choose the appropriate dosage form, as well as its method of preparation, on the basis of his general knowledge, taking into account on the one hand the nature of the constituents used, in particular their solubility in the support, and on the other hand of the application envisaged for the composition.

The composition according to the invention comprises a “physiologically acceptable medium”. The term "physiologically acceptable medium" means a medium suitable for the administration of a composition topically, and compatible with all keratin materials of human beings such as the skin, lips, nails, mucous membranes, eyelashes, eyebrows, scalp and/or hair, or any other skin area of the body.

According to the invention, a physiologically acceptable medium is preferably a cosmetically acceptable medium, that is to say without odor or unpleasant appearance, and which is perfectly compatible with the topical administration route.

More particularly, the composition according to the invention is suitable for topical administration, that is to say by application to the surface of the keratin material considered, such as the skin considered.

The compositions according to the invention are preferably cosmetic compositions for skin care and/or makeup.

These compositions are particularly intended for topical application to the face and/or body.

In particular, the composition is applied to the facial area, in particular the T zone (forehead, nose, cheeks, chin), in particular the forehead and the nose.

In a preferred embodiment of the invention, the composition according to the invention has a pH between 5 and 8, preferably between 5.5 and 7.

The cosmetic compositions according to the invention having a pH between 5 and 8, preferably having a pH of 5.5 and 7, have improved stability, in particular for the chemical ingredients present in said compositions.

Another object of the invention is a process for the cosmetic treatment of keratin materials in which a composition as defined above is applied to said keratin materials.

Another object of the invention is the use of a composition as defined above for the cosmetic treatment of keratin materials.

The present invention will now be described more specifically by means of examples, which are in no way limiting the scope of the invention. However, the examples make it possible to support specific characteristics, variants, and preferred embodiments of the invention.

Examples

In the examples, the temperature is given in degrees Celsius, and corresponds to ambient temperature (20-25°C), unless otherwise stated, and the pressure is atmospheric pressure at sea level, unless otherwise stated. Furthermore, the percentages are mentioned by weight relative to the total weight of the composition unless otherwise indicated.

Phase A raw materials (lipophilic UV filters, alcohols and fatty acids, hydrophobic surfactants, isopropyl isostearate, isopropyl myristate, other oils, hydrophobic actives and hydrophobic preservatives and antioxidant) are added to the main tank and heated to between 65 and 80° C until total homogenization of the phase.

The raw materials of phase B (21% water, 3% glycerin, dyes, hydrophilic active ingredients, glycols, chelating agent, hydrophilic preservatives, hydrophilic UV filter) are added to the main tank and homogenized. The phase is maintained at a temperature between 65 and 80°C.

Phase B is introduced into phase A at a temperature between 65 and 80°C under rotor/stator.

Phase C containing the polymers and phase D containing the silicones are then added successively.
Control of sensory and cosmetic properties:

For each of the following compositions, the cosmetic properties were evaluated according to the following protocol.

The cosmetic properties upon application are evaluated, individually, by a panel of experts trained in the description of care products. The sensory evaluation of care products by this panel is carried out as follows: the products are packaged in jars. Within the same session, the samples are presented in randomized order for each panelist. These first assess the grip and flexibility in the pot (= pick-up). They then place a drop of product (0.05 mL) on the back of the hand and evaluate the slipperiness upon application then the transformation of the texture into oil by performing 15 turns in 15 seconds with the index and middle fingers. Then the experts evaluate the comfort which is defined by the greasy film (more or less oily or waxy on the skin) and the softness after a few seconds of penetration.

The descriptors are rated on a scale from 1 to 5: 1 = not, 2 = a little, 3 = moderately, 4 = quite a bit, 5 = very.

The sensory parameters evaluated for the compositions tested are as follows:

– “Pick-up” (or firmness when setting): this parameter allows you to evaluate the soft/stringy nature of the composition (1) or thick/rebound (5) when setting in the pot. For the compositions according to the invention, a firmness to the grip is expected which is balanced (neither too flexible/stringy, nor too thick/bouncy).

– Spreadability: this property is measured through the following 2 parameters: slipperiness upon application and transformation into oil. Concerning the slipperiness on application, it goes from the least slippery (1) to the most slippery (5). For the compositions according to the invention, it is expected that the slipperiness is as strong as possible. Concerning the transformation into oil, the latter ranges from a texture that is not at all transformative (called “continuous”) (1) to a significant transformation into oil (5). For the compositions according to the invention, it is expected that the latter do not have very transformative textures.

– The “skin finish”: this property is measured using the following 2 parameters: oiliness (oily/waxy) and softness (sticky/soft). Concerning the fatty character, it ranges from oily (1) to waxy (5). For the compositions according to the invention, it is expected that the fatty character is as oily as possible to avoid a rough skin finish. Concerning softness, the latter ranges from sticky (1), which gives stickiness, to soft (5). For the compositions according to the invention, it is expected that the softness is as less sticky as possible (and therefore that the composition is as less sticky as possible after spreading).

The results obtained for the different compositions tested are presented in Table 2 below. Only compositions 1 and 4 according to the invention make it possible to obtain the expected firmness, spreading and skin finish.

Claims (19)

Cosmetic or dermatological composition in the form of an emulsion comprising in a physiologically acceptable support:
a) at least one aqueous phase
b) at least one oily phase
c) at least one copolymer comprising at least one monomer of 2-acrylamido-2-methylpropane sulfonic acid (AMPS®) and at least one monomer with a hydrophobic group,
d) at least one emulsifying system comprising at least one alkylpolyglucoside.
e) at least one UV filter, and
f) isopropyl myristate. Composition according to claim 1, characterized in that the AMPS® copolymer(s) are crosslinked by a crosslinking agent, preferably trimethylol propane triacrylate. Composition according to any one of the preceding claims, characterized in that the monomer(s) of 2-acrylamido-2-methylpropane sulfonic acid are completely salified, preferably in the form of ammonium salt. Composition according to any one of the preceding claims, characterized in that the monomer with a hydrophobic group is chosen from acrylates or acrylamides of formula (II):
(II)
in which R ₁ denotes a hydrogen atom or a linear or branched C ₁ -C ₆ alkyl radical, preferably methyl; Y denotes O or NH; R ₂ designates a hydrocarbon radical comprising from 6 to 50 carbon atoms and more preferably from 6 to 22 carbon atoms and even more preferably from 12 to 18 carbon atoms; x denotes a number ranging from 0 to 100. Composition according to claim 4 characterized in that in formula (II), Y designates an oxygen atom, the group R ₁ represents a methyl, the group R ₂ represents an alkyl radical comprising from 12 to 18 carbon atoms, x represents an integer between 3 and 25. Composition according to any one of Claims 4 or 5, characterized in that the monomer with a hydrophobic group of formula (II) is ethoxylated stearyl methacrylate (25OE) corresponding to the compound of formula (II) in which the group R ₁ represents a methyl, the group Y denotes O, the group R ₂ represents an alkyl radical containing 18 carbon atoms and x is equal to 25. Composition according to any one of the preceding claims, characterized in that the AMPS® copolymer is a copolymer of 2-acrylamido-2-methylpropane sulfonic acid, preferably completely salified, preferably in the form of ammonium salt and methacrylate of ethoxylated stearyl (25OE). Composition according to any one of the preceding claims, characterized in that the AMPS® copolymer(s) are present in the composition in a content ranging from 0.01 to 10% by weight, more preferably from 0.05 to 5% by weight. weight and even more preferably from 0.1 to 2% by weight relative to the total weight of the composition. Composition according to any one of the preceding claims, characterized in that the alkylpolyglucoside(s) are chosen from the following compounds of formula (IV):
(IV)
in which :
- R ₁ denotes a linear or branched alkyl radical comprising from 6 to 30 carbon atoms, preferably from 6 to 24 carbon atoms, more preferably from 8 to 22, and even more preferably from 12 to 20;
- group G is a saccharide residue;
- a is a number from 1 to 10. Composition according to claim 9, characterized in that the saccharide residue is chosen from glucose, dextrose, sucrose, fructose, galactose, maltose, maltotriose, lactose, cellobiose, mannose, ribose, dextran, talose, allose, xylose, levoglucan, cellulose , starch and mixtures thereof, preferably glucose. Composition according to any one of the preceding claims, characterized in that the alkylpolyglucoside(s) are chosen from the arachidyl alcohol and behenyl alcohol/arachidylglucoside mixture, the cetylstearyl alcohol/cetylstearylglucoside mixture and their mixtures. Composition according to any one of the preceding claims, characterized in that the composition comprises at least one ester of fatty acid and/or fatty alcohol chosen from isopropyl isostearate, isopropyl palmitate, isononyl isononanoate , isostearyl isostearate and diisopropyl sebacate. Composition according to any one of the preceding claims, characterized in that the composition comprises at least one crosslinked (meth)acrylic acid homopolymer. Composition according to any one of the preceding claims, characterized in that the composition comprises at least one homopolymer of 2-acrylamido 2-methyl propane sulfonic acid (AMPS®). Composition according to any one of the preceding claims, characterized in that the composition comprises at least one acyl glutamic acid chosen from acyl glutamic acids whose acyl group comprises from 10 to 30 carbon atoms, preferably from 12 to 22 carbon atoms such as lauroyl glutamic acid, myristoyl glutamic acid, palmitoyl glutamic acid, stearoyl glutamic acid, behenoyl glutamic acid, olivoyl glutamic acid, cocoyl glutamic acid, and mixtures thereof. Composition according to any one of the preceding claims, characterized in that the composition comprises at least one alkyl- and polyalkyl-esters of poly(ethylene oxide) having a number of ethylene oxide units (0E) ranging from 2 to 200. Composition according to any one of the preceding claims, characterized in that the composition comprises at least one organic UV filter chosen from Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Triazone, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, and their mixtures. Process for the cosmetic treatment of keratin materials in which a composition as defined according to any one of claims 1 to 17 is applied to said keratin materials. Use of a composition as defined according to any one of claims 1 to 17 for the cosmetic treatment of keratin materials.